XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF CONTRACT LIABILITIES

  

   March 31, 2024 
   December 31, 2023   Additions/Reclass   Recognized Revenue   March 31, 2024 
Contract liabilities, current  $2,937,168   $535,598   $173,052   $3,299,714 
Contract liabilities, non-current   7,340,459    13,066    68,319    7,285,206 
                     
   $10,277,627   $548,664   $241,371   $10,584,920 

 

   March 31, 2023 
   December 31, 2022   Additions/Reclass   Recognized Revenue   March 31, 2023 
Contract liabilities, current  $2,154,874   $562,809   $92,813   $2,624,870 
Contract liabilities, non-current   5,818,082    868,211    370,646    6,315,647 
                     
   $7,972,956   $1,431,020   $463,459   $8,940,517 
SCHEDULE OF SHORT TERM INVESTMENTS

Cash and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less. The following table shows the Company’s cash and cash equivalents by significant investment category as of March 31, 2024 and December 31, 2023:

  

   March 31, 2024 
   Adjusted
Cost
   Realized
Gains
   Realized
Losses
   Fair Value 
Demand deposits  $769,982   $   $   $769,982 
Short-term investments with original maturities of 90 days or less (Level 1):                    
Money market funds   157,879            157,879 
                     
   $927,861   $   $   $927,861 

 

   December 31, 2023 
   Adjusted
Cost
   Realized
Gains
   Realized
Losses
   Fair Value 
Demand deposits  $545,207   $   $   $545,207 
Short-term investments with original maturities of 90 days or less (Level 1):                    
Money market funds   135,342            135,342 
                     
   $680,549   $   $   $680,549 
SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS

The following table provides a reconciliation of cash and cash equivalents in the consolidated balance sheets to cash, cash equivalents and restricted cash in the consolidated statements of cash flows:

  

   March 31, 2024   December 31, 2023 
Cash and cash equivalents  $927,861   $680,549 
Long-term restricted cash included in other assets   97,600    97,600 
Total cash, cash equivalents and restricted cash in the statements of cash flows  $1,025,461   $778,149